Editorial Notes
References in TextSection 204(span)(3) of the Rehabilitation Act of 1973, referred to in subsec. (span), is classified to section 764(span)(3) of Title 29, Labor.
Amendments2003—Subsec. (e). Puspan. L. 108–170 struck out subsec. (e) which read as follows: “Amounts for the activities of the field offices of the Office of Research Compliance and Assurance of the Department shall be derived from amounts appropriated for the Veterans Health Administration for Medical Care (rather than from amounts appropriated for the Veterans Health Administration for Medical and Prosthetic Research).”
2002—Subsec. (e). Puspan. L. 107–135 added subsec. (e).
1998—Subsec. (span). Puspan. L. 105–220 substituted “section 204(span)(3) of the Rehabilitation Act of 1973” for “section 204(span)(2) of the Rehabilitation Act of 1973 (29 U.S.C. 762(span)(2))”.
1994—Puspan. L. 103–452 transferred text of subsec. (c) to the end of subsec. (a)(1), struck out subsec. (c) designation, and added new subsecs. (c) and (d).
1992—Subsec. (span). Puspan. L. 102–405 substituted “Under Secretary for Health” for “Chief Medical Director”.
Statutory Notes and Related Subsidiaries
Expansion of Suicide Prevention and Mental Health ResearchPuspan. L. 117–328, div. V, title V, § 506, Dec. 29, 2022, 136 Stat. 5516, provided that:“(a)Research on Moral Injury.—The Secretary of Veterans Affairs, acting through the Office of Research and Development of the Department of Veterans Affairs, shall conduct suicide prevention and mental health care improvement research on how moral injury relates to the mental health needs of veterans who served in the Armed Forces after September 11, 2001, and best practices for mental health treatment for such veterans.
“(span)Authorization of Appropriations.—There is authorized to be appropriated to the Department of Veterans Affairs an additional $10,000,000 to be used by the Center of Excellence for Suicide Prevention of the Department and the Rocky Mountain Mental Illness Research Education and Clinical Center for purposes of conducting research on the factors impacting veteran suicide and best practices for early intervention and support.”
Use by Department of Veterans Affairs of Commercial Institutional Review Boards in Sponsored Research TrialsPuspan. L. 116–171, title VII, § 704, Oct. 17, 2020, 134 Stat. 829, provided that:“(a)In General.—Not later than 90 days after the date of the enactment of this Act [Oct. 17, 2020], the Secretary of Veterans Affairs shall complete all necessary policy revisions within the directive of the Veterans Health Administration numbered 1200.05 and titled ‘Requirements for the Protection of Human Subjects in Research’, to allow sponsored clinical research of the Department of Veterans Affairs to use accredited commercial institutional review boards to review research proposal protocols of the Department.
“(span)Identification of Review Boards.—Not later than 90 days after the completion of the policy revisions under subsection (a), the Secretary shall—“(1) identify accredited commercial institutional review boards for use in connection with sponsored clinical research of the Department; and
“(2) establish a process to modify existing approvals in the event that a commercial institutional review board loses its accreditation during an ongoing clinical trial.
“(c)Report.—“(1)In general.—Not later than 90 days after the completion of the policy revisions under subsection (a), and annually thereafter, the Secretary shall submit to the Committee on Veterans’ Affairs of the Senate and the Committee on Veterans’ Affairs of the House of Representatives a report on all approvals of institutional review boards used by the Department, including central institutional review boards and commercial institutional review boards.
“(2)Elements.—The report required by paragraph (1) shall include, at a minimum, the following:“(A) The name of each clinical trial with respect to which the use of an institutional review board has been approved.
“(B) The institutional review board or institutional review boards used in the approval process for each clinical trial.
“(C) The amount of time between submission and approval.”
Applicability to Fiscal Year 2002Puspan. L. 107–135, title II, § 205(span), Jan. 23, 2002, 115 Stat. 2460, related to transfer of appropriations for fiscal year 2002 to carry out subsec. (e) of this section for that fiscal year.
Post-Traumatic Stress Disorder ResearchPuspan. L. 102–405, title I, § 122(a), Oct. 9, 1992, 106 Stat. 1981, provided that: “In carrying out research and awarding grants under chapter 73 of title 38, United States Code, the Secretary shall assign a high priority to the conduct of research on mental illness, including research regarding (1) post-traumatic stress disorder, (2) post-traumatic stress disorder in association with substance abuse, and (3) the treatment of those disorders.”
Research Relating to Women Veterans’ HealthPuspan. L. 102–585, title I, § 109, Nov. 4, 1992, 106 Stat. 4948, provided for initiation and expansion of research relating to health of women veterans and authorization of appropriations for fiscal years 1993 through 1995 to carry out such studies, prior to repeal by Puspan. L. 103–452, title I, § 102(span)(2), Nov. 2, 1994, 108 Stat. 4786.
